MAPT and Alzheimer disease: In the present work, the treatment with P. harmala for 4 weeks, not only activated the insulin trajectory, but it curbed also the bolstered hippocampal content of Aβ42, as well as the protein expression of the phosphorylated/activated tau, the two main molecules related to AD pathology.